Hansen Medical Inc (HNSN) 3.99 $HNSN HANSEN MEDICAL

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hansen Medical Inc (HNSN) 3.99 $HNSN

HANSEN MEDICAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Hansen Medical, Inc. (HNSN) Over the Proposed Sale of the Company to Auris Surgical Robotics, Inc.
BusinessWire - Wed Apr 27, 3:35PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Hansen Medical, Inc. ("Hansen Medical" or the "Company" (NASDAQ:HNSN) for potential breaches of fiduciary duties in connection with the sale of the Company to Auris Surgical Robotics, Inc. for approximately $80 million in an all-cash transaction.
HNSN: 3.99 (unch)

INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Hansen Medical, Inc. and Encourages Shareholders to Contact the Firm for Additional Information
BusinessWire - Tue Apr 26, 2:20PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Hansen Medical Inc. (Hansen or the "Company" (Nasdaq: HNSN) relating to the proposed buyout of the Company by Auris Surgical Robotics, Inc.
HNSN: 3.99 (unch)

Hansen Medical(R) Announces Filing of 510K for Expanded Neurological Indication for Magellan(TM) Product Line
Marketwired - Tue Apr 26, 7:00AM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today provides an update on the status of its key corporate initiative to expand the utility and regulatory labeling of the Magellan(TM) product line.
HNSN: 3.99 (unch)

Hansen Medical(R) to Highlight Benefits and Future of Magellan(TM) Robotic System Technology and Present Magellan Robotic System at Charing Cross International Symposium
Marketwired - Mon Apr 25, 7:02AM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the Charing Cross International Symposium in London, United Kingdom from April 26th to April 29th.
HNSN: 3.99 (unch)

Ryan & Maniskas, LLP Announces Investigation of Hansen Medical, Inc.
PR Newswire - Fri Apr 22, 10:19AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Hansen Medical, Inc. ("Hansen Medical" or the "Company" (NASDAQ: HNSN) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Auris Surgical Robotics, Inc. in a transaction valued at approximately $80 million.
HNSN: 3.99 (unch)

Harwood Feffer LLP Announces Investigation of Hansen Medical, Inc.
PR Newswire - Thu Apr 21, 4:20PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Hansen Medical, Inc. ("Hansen" or the "Company" (NASDAQ: HNSN) concerning the proposed acquisition of the Company by Auris Surgical Robotics, Inc. ("Auris" .
HNSN: 3.99 (unch)

Hansen Medical, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Auris Surgical Robotics, Inc.
BusinessWire - Thu Apr 21, 1:24PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Hansen Medical, Inc. ("Hansen" (NASDAQ: HNSN) concerning the merger with Auris Surgical Robotics, Inc. Under the terms of the agreement, valued at approximately $80 million, Hansen shareholders will only receive $4.00 per share held.
HNSN: 3.99 (unch)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Hansen Medical, Inc. -HNSN
PR Newswire - Wed Apr 20, 9:35PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Hansen Medical, Inc. ("Hansen Medical" or "the Company" (Nasdaq- HNSN-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Auris Surgical Robotics, Inc. ("Auris" .
HNSN: 3.99 (unch)

SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Hansen Medical, Inc. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Wed Apr 20, 9:20PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Hansen Medical Inc. (Hansen or the "Company" (Nasdaq: HNSN) relating to the proposed buyout of the Company by Auris Surgical Robotics, Inc.
HNSN: 3.99 (unch)

HANSEN MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Wed Apr 20, 10:29AM CDT
Rigrodsky & Long, P.A.:
HNSN: 3.99 (unch)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of Hansen Medical, Inc. for $4.00 Per Share to Auris Surgical Robotics, Inc. is Fair to Shareholders
ACCESSWIRE - Wed Apr 20, 9:21AM CDT
NEW YORK, NY / ACCESSWIRE / April 20, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
HNSN: 3.99 (unch)

HANSEN (HNSN) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Hansen Medical, Inc.; Are Hansen Shareholders Getting a Fair Price?
PR Newswire - Wed Apr 20, 8:34AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Hansen Medical, Inc. (NASDAQ: HNSN) breached their fiduciary duties in connection with the proposed sale of the Company to Auris Surgical Robotics, Inc.
HNSN: 3.99 (unch)

HANSEN BUYOUT ALERT - National Securities Law Firm Seeks Higher Price for Hansen Medical Shareholders in Connection with Proposed Buyout, and Encourages Shareholders to Contact Law Firm for More Information
PR Newswire - Wed Apr 20, 7:40AM CDT
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the potential sale of Hansen Medical, Inc. (NASDAQ: HNSN) ("Hansen" or the "Company" on behalf of its shareholders. Hansen announced that it has entered into a definitive agreement to be acquired by Auris Surgical Robotics, Inc. for $4 per share. In addition, certain significant shareholders of Hansen have agreed to invest approximately $49 million into Auris contemporaneously with the closing of the transaction.
HNSN: 3.99 (unch)

Auris Surgical Robotics Agrees to Acquire Hansen Medical
Marketwired - Wed Apr 20, 7:01AM CDT
Auris Surgical Robotics, Inc. and Hansen Medical, Inc. (NASDAQ: HNSN) today announced that they have signed a definitive merger agreement under which Auris will acquire Hansen Medical for $4.00 per share in cash, or a total equity value of approximately $80 million. The purchase price per share represents a premium of approximately 39.9% over the closing sale price of common stock of Hansen Medical as reported on NASDAQ on April 19, 2016. In addition, certain significant stockholders of Hansen Medical have agreed to invest approximately $49 million into Auris contemporaneously with the closing of the transaction.
HNSN: 3.99 (unch)

Hansen Medical(R), Inc. Receives NASDAQ Letter Regarding Late Form 10-K Filing
Marketwired - Wed Apr 06, 4:00PM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN) today announced that it received a notification letter on March 31, 2016 from The NASDAQ Stock Market ("NASDAQ" . The notification letter stated that because the Company has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2015 (the "Form 10-K" , the Company is no longer in compliance with NASDAQ Marketplace Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission (the "SEC" .
HNSN: 3.99 (unch)

Hansen Medical(R) to Demonstrate New Magellan(TM) Robotic Catheter eKit and Present Magellan Robotic System at 41st Annual Society of Interventional Radiology (SIR) Scientific Meeting
Marketwired - Thu Mar 17, 7:00AM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the Annual Society of Interventional Radiology (SIR) Scientific Meeting April 2-7 in Vancouver, British Columbia, Canada. The Company will showcase the newly approved Magellan Robotic Catheter eKit that has been used by Interventional Radiologists in a variety of procedures, including Uterine Fibroid Embolization (UFE), Bilateral Renal Embolization, and Radioembolization. The Magellan Robotic System and the family of Magellan Robotic Catheters will be demonstrated at exhibit booth # 1038.
HNSN: 3.99 (unch)

4 Stocks That are Making Big Moves Early Today
ACCESSWIRE - Tue Feb 02, 9:23AM CST
NEW YORK, NY / ACCESSWIRE / February 2, 2016 / The Stock Expert is issuing a report on four stocks to watch. HDP, EYEG, LOJN and HNSN have been attracting the attention of major investors today. Continue reading to find out why. - To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.
HDP: 12.39 (+0.68), HNSN: 3.99 (unch), LOJN: 6.44 (-0.01), EYEG: 2.09 (+0.07)

Hansen Medical(R) Announces Latest Publication in the Journal of Interventional Cardiac Electrophysiology
Marketwired - Mon Feb 01, 7:00AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the latest publication in the Journal of Cardiac Electrophysiology: Analysis of catheter contact force during atrial fibrillation ablation, using the robotic navigation system: results from a randomized study.
HNSN: 3.99 (unch)

BUYINS.NET Issues Hansen Medical (HNSN) SqueezeTrigger Report
M2 - Wed Jan 27, 6:52AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Hansen Medical, Inc. (NASDAQ: HNSN) after releasing the latest short sale data through January 26, 2016. The total aggregate number of shares shorted since August 2009 is approximately 24.35 million shares. Approximately 29.31% of daily trading volume is short selling. The SqueezeTrigger price for all HNSN shares shorted is $23.67. Approximately 459,000 total shares have been shorted below $3.00 and are expected to squeeze when the stock exceeds this level.
HNSN: 3.99 (unch)

The Life Sciences Report Interviews Alan Leong of BioWatch News
Marketwired - Fri Jan 22, 8:00AM CST
Combining academic discipline with methodical due diligence, Alan Leong of BioWatch News undertakes a regimented review of each biotech and medtech stock he investigates. In some cases he will follow a company's clinical development program and data for years before he pulls the trigger and recommends a name. In this interview with The Life Sciences Report, Leong presents a number of names for investors' consideration. Many won't be mentioned in his usual write-ups: It's an early look at what's on his watch list and in his inbox. Each company carries its own risks, but every stock has a special growth story that could propel huge gains if data fall into place.
CPH.TO: 6.58 (+0.03), RVX.TO: 1.19 (-0.01), HNSN: 3.99 (unch), CPHR: 4.96 (-0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thanksgiving Dog Safety Is a Pet Care Reality Check

Updated Category News Views 0

A crowded Thanksgiving kitchen can turn a well-behaved dog into a scavenger with lousy odds. Camp Bow Wow’s holiday guidance is not pretending the meal itself is the problem; the trouble is that a house full of distracted people, rich food and unsecured trash creates a pile of easy mistakes. For pet owners, that is a fair reminder. For anybody watching the pet-care...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 9

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Washington-to-Asia Advisory Deal Targets Policy Risk

Updated Category News Views 0

Policy bottlenecks are becoming a cost center across Southeast Asia. That is the plain-English backdrop for the strategic partnership announced November 18, 2026, by Beacon Global Strategies and Vriens & Partners. Neither firm is selling a factory, a chip design, or a new energy project. They are selling something companies increasingly cannot afford to improvise: a...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 206

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Tactical Tomahawk Motor Deal Puts Propulsion in Focus

Updated Category News Views 31

A missile program lives or dies on unglamorous hardware, and solid rocket motors are about as unglamorous as it gets until somebody cannot build enough of them. Raytheon has awarded Ursa Major and Avio USA a joint contract to develop solid rocket motors for the U.S. Navy’s Tactical Tomahawk missile program. That is the whole headline, and it matters more than the thin...

Continue Reading
Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 127

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
Google Search Data Sharing Faces a Privacy Reality Check

Updated Category News Views 91

Search queries are messy little confessions, and that is exactly why this case deserves more than a bureaucratic shrug. Woodway Assurance's independent assessment says Google's search-query data could be treated as anonymized for sharing under the Digital Markets Act, but only if the European Commission tightens parts of its July 2026 framework. That is not a clean bill...

Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal

Updated Category News Views 49

Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 157

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 46

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading

Top 5 Most Recently Viewed Articles

AbbVie's Options Activity: Understanding the Market Trends

Updated Category News Views 188

Understanding AbbVie’s Recent Options Activity Recently, there has been a notable shift in the options trading landscape surrounding AbbVie (NYSE: ABBV). Investors with significant capital seem to be leaning towards a bearish outlook regarding AbbVie. This movement in options trading is particularly important for retail traders to consider. What’s Behind the Trading...

Continue Reading
Innovative Trends at Spielwarenmesse: A Toy Industry Showcase

Updated Category News Views 271

Exploring the Spielwarenmesse: The Ultimate Toy Expo The Spielwarenmesse has established itself as a pivotal platform for the global toy industry. Showcasing creativity, innovation, and networking opportunities, this event gathers notable participants from across the toy spectrum. Diverse Exhibitors and Cutting-Edge Innovations With over 2,362 exhibitors representing 71...

Continue Reading
Nota AI and Renesas: Revolutionizing Driver Monitoring Technology

Updated Category News Views 173

Collaboration Between Nota AI and Renesas Nota AI, known for its expertise in AI optimization, has announced an exciting partnership with Renesas Electronics Corporation, aiming to advance driver monitoring technology through the optimized Driver Monitoring System (DMS). This collaboration is particularly focused on the new RA8P1 microcontroller unit (MCU), which is...

Continue Reading
Bureau Veritas Expands in Renewables with ArcVera Acquisition

Updated Category News Views 74

Bureau Veritas Expands in the Renewable Energy Sector Bureau Veritas, a global leader in testing, inspection, and certification services, has recently made a significant move by acquiring ArcVera Renewables. This strategic acquisition aims to strengthen Bureau Veritas's position in the fast-growing renewable energy sector across North America. Strategic Alignment with...

Continue Reading
Understanding T. Rowe Price Group's Earnings Expectations

Updated Category News Views 170

Anticipating T. Rowe Price Group's Earnings Announcement T. Rowe Price Gr (TROW) is poised to announce its quarterly earnings soon. Investors are keenly focused on the impending announcement, hoping for positive results that exceed expectations. As the company prepares for the reporting date, understanding what to anticipate can be essential for informed investment...

Continue Reading